Silo Pharma announced USPTO's Notice of Allowance for a patent protecting its PTSD treatment, SPC-15, enhancing its IP portfolio. Silo Pharma, Inc. announced that the U.S. Patent and Trademark Office ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results